Global COVID-19 Diagnostics Market Report 2022: A New Very Large and Sustainable Market for COVID Related Diagnostics is Emerging

News provided by

Mar 28, 2022, 17:30 ET

DUBLIN, March 28, 2022 /PRNewswire/ -- The "COVID-19 Diagnostics: Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country - Assay Volumes and Market Size Outlook. Updated to include 2021 Actuals" report has been added to ResearchAndMarkets.com's offering.

The pandemic may be ending but COVID-19 is here to stay.

Who won the biggest share of the COVID Diagnostics market? How many tests were performed last year? 2021 broke all the records as COVID-19 testing reached all time highs in the final months of the year.

Find out about this and the outlook for the years ahead. This is still a dynamic market as multiple competitors are vying for the very lucrative future for respiratory diagnostics.

The Omicron Variant has changed the pandemic outlook for the better. And we have changed ours. Get the revised outlook based on the latest data and our view of the regulatory response. And, considering that a new dynamic market is emerging for COVID-19 based diagnostics.

Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in the latest report.

Revenue, testing volumes, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with the Market Guides and Situation Analysis.

Make projections with confidence using the latest data. The report includes five-year market forecasts.

Covid-19 Diagnostics Recent Developments

Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
At-Home COVID Test Coverage
LuminUltra Wins 500-Site CDC Wastewater Testing Contract
Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
Tests Called Back
Cepheid Obtains CE Mark for Expanded Combo COVID Test
CRISPR Tests for SARS-CoV-2 Using Saliva Samples
CVS Limits Purchases of Rapid Covid-19 Tests
Illumina, COVID-19 Surveillance Continue to Boost Business
LetsGetChecked Closes $150M Funding Round
Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
Abbott Sees Sharp Decline in COVID-19 Test Revenue
Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
NY Times Explores Multiplex Testing
Hologic Banking on MDx Acquisitions
Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
LumiraDx to Go Public Through SPAC
Eurofins Test Helps to ID Mutations
Roche Sees Growing Opportunities for Diagnostics
Roche to Acquire GenMark Diagnostics for $1.8B
Fulgent Genetics s to Use COVID-19 Testing Gains to Grow Clinical Sequencing
LexaGene Syndromic Panel Platform Lets Labs Customize Targets
FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
At-Home Infectious Disease Test Developer Lucira Health Goes Public

Market Definition

Assay Volumes
PCR
PCR Multiplex
SEQ
Antigen
Antibodies
Instruments
Reagents and Kits
Extract
Collect
Public
Hospital
Clinic
Workplace
DTC/OTC
Wastewater

Diagnostic Company Profiles

Abacus Diagnostica
Abbott Diagnostics
Accelerate Diagnostics
Acces Bio
Advanced Biological Laboratories
Agena Bioscience, Inc.
Agilent/Dako
Altona Diagnostics
Alveo Technologies
Anatolia Geneworks
Applied BioCode
Applied DNA Sciences
Assurance Scientific Laboratories
Aus Diagnostics
Autobio Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
BillionToOne
Binx Health
Biocartis
Biodesix Inc.
BioFire Diagnostics (bioMerieux)
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Reference Laboratories
Bosch Healthcare Solutions GmbH
Cepheid (Danaher)
Chembio
Co Diagnostics
Color Genomics
Cue Health
Curetis N.V. / Curetis GmbH
Diagenode Diagnostics
Diasorin S.p.A.
Ellume
Enzo Life Sciences, Inc.
Everywell
Fluxergy
Fujirebio
Fulgent Genetics
Fusion Genomics.
Genedrive
Genetic Signatures
GenMark Dx (Roche)
Gold Standard Diagnostics
Hologic
Illumina
Immunexpress
Inflammatix
Janssen Diagnostics
Karius
Laboratory Corporation of America
Letsgetchecked
Lexagene
Luminex Corp
LumiraDx
Mammoth Biosciences
Mayo Clinic Laboratories
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
Mobidiag (Hologic)
Nanomix
Novacyt
OraSure Technologies
Ortho Clinical Diagnostics
Oxford Nanopore Technologies
Perkin Elmer
Primerdesign (Novacyt)
Prominex
Qiagen
QuantuMDx
Quest Diagnostics
Quidel
Randox Toxicology
Roche Molecular Diagnostics
SD Biosensor
Seegene
Sense Biodetection
Sherlock Biosciences
Siemens Healthineers
Sona Nanotech
SpeeDx
Thermo Fisher Scientific Inc.
Veredus Laboratories
Vircell
Visby Medical
YD Diagnostics
Zhejiang Orient Gene Biotech

For more information about this report visit https://www.researchandmarkets.com/r/pozoab

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets